Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats

다국어 초록 (Multilingual Abstract)

Objective: Purinergic 2X7 receptor (P2X7R) activation is known to be involved in pathogenesis of depression. Our aims were to investigate P2X7R-activated inflammasome pathways in parallel with induction of depression and to test the antidepressant-like effects of the selective P2X7R antagonist Brilliant Blue G (BBG) in a rat model of chronic unpredictable mild stress (CUMS).
Methods: Male Wistar albino rats were divided into control, CUMS, CUMS＋BBG25 (25 mg/kg/day) and CUMS＋BBG50 (50 mg/kg/day) groups (n=10 for each group). Various stressors were applied to rats for 6 weeks to establish the CUMS model and daily BBG treatment was started at the end of 3rd week. Sucrose preference test and forced swim test (FST) were performed to assess antidepressant-like effects. Brain samples were obtained for real-time polymerase chain reaction and immunohistochemistry analysis.
Results: In FST, duration of immobility was reduced in the CUMS＋BBG50 group. Also, BBG treatment significantly enhanced sucrose preference. While NLRP3 gene expression levels were unchanged in rats exposed to the CUMS protocol, expression levels of other inflammasome pathway factors NLRP1, caspase-1, ASC, NF-B, IL-1, IL-6 and P2X7R were increased. BBG treatment reduced expression levels of these factors. Likewise, Iba-1 and GFAP immunoreactivities were enhanced by the CUMS protocol and this action was reversed by BBG treatment.
Conclusion: Chronic administration of BBG in CUMS model results in antidepressant-like activity in a dose dependent manner. Molecular and histological results show that these effects might be at least partially related to the suppression of inflammasome-related neuroinflammatory responses and suggest involvement of NLRP1 in depression.

참고문헌 (Reference)

1 Culpepper L, "Why do you need to move beyond first-line therapy for major depression" 71 (71): 4-9, 2010

2 Willner P, "Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation" 134 : 319-329, 1997

3 Di Virgilio F, "The therapeutic potential of modifying inflammasomes and NOD-like receptors" 65 : 872-905, 2013

4 Miller AH, "The role of inflammation in depression : from evolutionary imperative to modern treatment target" 16 : 22-34, 2016

5 Réus GZ, "The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders" 300 : 141-154, 2015

6 Freeman LC, "The pathogenic role of the inflammasome in neurodegenerative diseases" 136 (136): 29-38, 2016

7 Sahin C, "The neuroinflammation perspective of depression : reuniting the outstanding mechanisms of the pathophysiology" 26 : 196-206, 2016

8 Iwata M, "The inflammasome : pathways linking psychological stress, depression, and systemic illnesses" 31 : 105-114, 2013

9 Menken M, "The global burden of disease study : implications for neurology" 57 : 418-420, 2000

10 Wilkinson SM, "The first CNS-active carborane : a novel P2X7 receptor antagonist with antidepressant activity" 5 : 335-339, 2014

11 Kessler RC, "The costs of depression" 35 : 1-14, 2012

12 Wang Y, "TLR4-NF-B signal involved in depressive-like behaviors and cytokine expression of frontal cortex and hippocampus in stressed C57BL/6 and ob/ob mice" 2018 : 7254016-, 2018

13 Peng W, "Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury" 106 : 12489-12493, 2009

14 Liu W, "Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins" 227 : 126-135, 2018

15 Alcocer-Gómez E, "Stress-induced depressive behaviors require a functional NLRP3 inflammasome" 53 : 4874-4882, 2016

16 Guarda G, "Regulation of inflammasome activity" 130 : 329-336, 2010

17 Yang C, "Quantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depression" 17 : 93-102, 2018

18 Iwata M, "Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor" 80 : 12-22, 2016

19 Olivia May Dean, "Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial" 대한정신약물학회 12 (12): 180-188, 2014

20 Izabela G. Barbosa, "Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder" 대한정신약물학회 15 (15): 269-275, 2017

21 Song Y, "Perilla aldehyde attenuates CUMS-induced depressive-like behaviors via regulating TXNIP/TRX/NLRP3 pathway in rats" 206 : 117-124, 2018

22 Kigerl KA, "Pattern recognition receptors and central nervous system repair" 258 : 5-16, 2014

23 Soronen P, "P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts" 156B : 435-447, 2011

24 Nagy G, "P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients" 32 : 1884-1888, 2008

25 Wang YC, "Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats" 12 : 2149-2154, 2015

26 Csölle C, "Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors" 8 : e66547-, 2013

27 Kaufmann FN, "NLRP3 inflammasome-driven pathways in depression : clinical and preclinical findings" 64 : 367-383, 2017

28 Zhang Y, "NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation" 18 : pyv006-, 2015

29 Alcocer-Gómez E, "NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder" 36 : 111-117, 2014

30 Xu Y, "NLRP3 inflammasome activation mediates estrogen deficiency-induced depression-and anxiety-like behavior and hippocampal inflammation in mice" 56 : 175-186, 2016

31 Wang YL, "Microglial activation mediates chronic mild stress-induced depressive-and anxiety-like behavior in adult rats" 15 : 21-, 2018

32 Pan Y, "Microglial NLRP3 inflammasome activation mediates IL-1-related inflammation in prefrontal cortex of depressive rats" 41 : 90-100, 2014

33 Xue J, "L-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters" 134 : 42-48, 2015

34 Lu M, "Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis" 17 : 1501-1510, 2014

35 Zhang Y, "Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors" 20 : 119-124, 2014

36 Haapakoski R, "Innate and adaptive immunity in the development of depression : an update on current knowledge and technological advances" 66 : 63-72, 2016

37 Miller AH, "Inflammation and its discontents : the role of cytokines in the pathophysiology of major depression" 65 : 732-741, 2009

38 Strawbridge R, "Inflammation and clinical response to treatment in depression : a meta-analysis" 25 : 1532-1543, 2015

39 Kummer JA, "Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response" 55 : 443-452, 2007

40 Velasquez S, "Inflammasome activation in major depressive disorder : a pivotal linkage between psychological stress, purinergic signaling, and the kynurenine pathway" 80 : 4-5, 2016

41 Fehlings MG, "Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury" 30 (30): S109-S112, 2010

42 Liu B, "Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation" 294 : 193-205, 2015

43 Sahin C, "Future directions of cytokine hypothesis in depression : ‘NLRP3 inflamazomu’" 23 : 280-288, 2013

44 Min Ma, "Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration" 대한정신약물학회 12 (12): 31-36, 2014

45 Peng WF, "Different behavioral and pathological changes between epilepsy-associated depression and primary depression models" 83 : 212-218, 2018

46 Pamela Ferrari, "Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar Disorder" 대한정신약물학회 16 (16): 103-108, 2018

47 Porsolt RD, "Depression : a new animal model sensitive to antidepressant treatments" 266 : 730-732, 1977

48 Fleshner M, "Danger signals and inflammasomes : stress-evoked sterile inflammation in mood disorders" 42 : 36-45, 2017

49 Willner P, "Chronic mild stress-induced anhedonia : a realistic animal model of depression" 16 : 525-534, 1992

50 Willner P, "Chronic mild stress(CMS)revisited : consistency and behavioural-neurobiological concordance in the effects of CMS" 52 : 90-110, 2005

51 Wiborg O, "Chronic mild stress for modeling anhedonia" 354 : 155-169, 2013

52 Jiang LH, "Brilliant blue G selectively blocks ATP-gated rat P2X(7)receptors" 58 : 82-88, 2000

53 Lu K, "Brilliant blue G attenuates lipopolysaccharide-mediated microglial activation and inflammation" 8 : 599-608, 2013

54 Basso AM, "Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety : relevance for neuropsychiatric disorders" 198 : 83-90, 2009

55 Wei L, "BDNF/TrkB pathway mediates the antidepressant-like role of H2S in CUMS-exposed rats by inhibition of hippocampal ER stress" 20 : 252-261, 2018

56 Song MT, "Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-B/NLRP3 inflammasome axis" 39 : 1559-1570, 2018

57 Halmai Z, "Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms" 150 : 104-109, 2013

58 Hejjas K, "Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach" 150B : 295-299, 2009

59 Li R, "Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1 production and NLRP3 inflammasome activation in the rat brain" 296 : 318-325, 2016

60 Pereira VS, "Antidepressant-and anticompulsivelike effects of purinergic receptor blockade : involvement of nitric oxide" 23 : 1769-1778, 2013

61 Czéh B, "Animal models of major depression and their clinical implications" 64 : 293-310, 2016

62 Deussing JM, "Animal models of depression" 3 : 375-383, 2006

63 Abelaira HM, "Animal models as tools to study the pathophysiology of depression" 35 (35): S112-S120, 2013

64 Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020 : global burden of disease study" 349 : 1498-1504, 1997

65 Sahin C, "Agmatine reverses sub-chronic stress induced nod-like receptor protein 3(NLRP3)activation and cytokine response in rats" 119 : 367-375, 2016

66 Zhang ZT, "Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome" 13 : 71-, 2016

67 Kimbler DE, "Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice" 7 : e41229-, 2012

68 de Rivero Vaccari JP, "Activation and regulation of cellular inflammasomes : gaps in our knowledge for central nervous system injury" 34 : 369-375, 2014

69 Raison CL, "A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression : the role of baseline inflammatory biomarkers" 70 : 31-41, 2013